4//SEC Filing
Astex Pharmaceuticals, Inc 4
Accession 0001179110-13-015576
CIK 0000919722operating
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 7:34 PM ET
Size
13.3 KB
Accession
0001179110-13-015576
Insider Transaction Report
Form 4
Kola Ismail
Director
Transactions
- Disposition to Issuer
Director Stock Option(Right to buy)
2013-10-11−26,192→ 0 totalExercise: $0.92Exp: 2020-05-01→ Common Stock (26,192 underlying) - Disposition to Issuer
Director Stock Option(Right to buy)
2013-10-11−20,000→ 0 totalExercise: $2.10Exp: 2022-06-22→ Common Stock (20,000 underlying) - Disposition to Issuer
Director Stock Option(Right to buy)
2013-10-11−50,000→ 0 totalExercise: $2.94Exp: 2021-07-20→ Common Stock (50,000 underlying)
Footnotes (8)
- [F1]The option originally provided for vesting as to 1/4th of the shares on May 1, 2011 and as to 1/48th of the shares on each one month anniversary thereafter. Pursuant to the Agreement and Plan of Merger, dated September 5, 2013, between the Issuer, Otsuka Pharmaceutical Co., Ltd., and Autumn Acquisition Corporation (the "Merger Agreement"), the option vested in full immediately prior to the closing of the merger.
- [F2]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $198,535.36, which represents the difference between $8.50 and the exercise price of the option per share.
- [F3]The option originally provided for vesting as to 20% of the shares on July 20, 2011 and each one year anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
- [F4]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $278,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
- [F5]The option provided for vesting as to 1/4th of the shares on June 22, 2012 and on each three month anniversary thereafter.
- [F6]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $128,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
- [F7]The option originally provided for vesting as to 1/4th of the shares on June 13, 2013 and on each three month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
- [F8]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $78,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
Documents
Issuer
Astex Pharmaceuticals, Inc
CIK 0000919722
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000919722
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 7:34 PM ET
- Size
- 13.3 KB